BioCardia Says US Patent Office Has Granted Patent No: 11,986,611 Titled 'Radial And Transendocardial Delivery Catheter,' With Patent Term That Will Expire In 2036
Portfolio Pulse from Benzinga Newsdesk
BioCardia has announced that the US Patent Office has granted Patent No: 11,986,611 for their 'Radial And Transendocardial Delivery Catheter,' which will expire in 2036. This patent covers a method for advancing cardiac catheters through a patient's wrist to treat the heart.
June 07, 2024 | 11:01 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BioCardia has been granted a new patent for their 'Radial And Transendocardial Delivery Catheter,' which is valid until 2036. This patent could enhance their product offerings and market position in cardiac treatments.
The new patent strengthens BioCardia's intellectual property portfolio and could lead to advancements in their cardiac treatment solutions, potentially boosting their market position and revenue.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100